- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01163019
2D Strain Echocardiography for Diagnosing Chest Pain in the Emergency Room (2DSPER)
Utility of 2D Strain Echocardiography in Triage of Patients With Chest Pain in the Emergency Department
Background: Chest pain (CP) and suspected heart attack is the second most frequent complaint among patients presenting to the emergency department (ED). Present workup involves in-hospital observation for 6 - 48 hours and requires significant resources including imaging tests, some of which are invasive and involve radiation and radio-contrast agents, which can be toxic to the kidney.
CP can result from impaired blood supply to the heart muscle, which may result in impaired contraction of the heart that persists for several days. Bedside echocardiography with semi-automated speckle tracking strain analysis (2D strain) is a novel promising noninvasive tool for the evaluation of heart muscle contraction. 2D strain can be useful for evaluating patients with CP, since it can accurately detect minor impairment in heart muscle contraction that can identify patients with coronary artery disease (CAD) and impending heart attack (coronary arteries are the arteries supplying blood to the heart muscle).
Working hypothesis and aims: The investigators hypothesize that a bedside echo study with normal 2D strain may allow quick and safe ruling out of a heart attack and significant CAD disease as the cause of CP.
The main aim of the study is to validate the investigators preliminary findings in a large number of patients in order to establish whether a normal 2D strain can safely rule out a heart attack or life threatening CAD.
Methods: In a large multi-center study 1200 patients presenting to the ED with acute CP of an unclear cause will undergo echocardiography as close as possible to presentation and not more than 24 hours from cessation of pain. Patients will undergo standard workup by the ED physicians. Standard echocardiographic findings, but not the 2D strain analysis, will be made available to the attending physician. Data from discharge letters, ECGs, blood tests, stress tests, nuclear imaging, heart CT and heart catheterization will be collected. A 6-month follow-up telephone interview will be performed to collect data on survival, heart attacks, re-hospitalization and revascularization (opening heart vessels blockages). 2D strain analysis will be performed off-line in a central laboratory to evaluate the ability of 2D strain to distinguish between patients with CP from heart disease and patients without life threatening heart disease that can be early released home safely.
Expected results: The investigators expect, based on the investigators previous experience, that patients with normal 2D strain will have a very low probability of a heart attack and significant CAD. The investigators further expect these patients to have an excellent 6-month prognosis. This will allow their early and cost-effective discharge.
Importance and Probable implications to Medicine: Reduction in ED patient load and a decrease in unnecessary hospitalizations for CP. Cost and resource savings and elimination of unnecessary imaging studies, some of which are invasive or involve radiation and contrast agents.
Aperçu de l'étude
Statut
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
-
Afula, Israël
- Ha'Emek Medical Center,
-
Beer Sheva, Israël
- Soroka University Medical Center
-
Hadera, Israël
- Hillel Yafe Medical Center
-
Haifa, Israël
- Lady Davis Carmel Medical Center
-
Jerusalem, Israël
- Shaare Zedek Medical Center
-
Jerusalem, Israël
- Hadassah-Hebrew University Medical Center, Mount Scopus
-
Jerusalem, Israël
- Hadassah-University Medical Center, Ein Kerem
-
Petah Tikva, Israël
- Rabin Medical Center
-
Rehovot, Israël
- Kaplan Medical Center
-
Tel Hashomer, Israël
- Chaim Sheba Medical Center
-
Zrifin, Israël
- Assaf Harofeh Medical Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
Patients presenting to the emergency department with chest pain characteristic for ischemia and suspected acute coronary syndrome and at least one of the following:
- Planned emergency department or chest pain unit observation for at least 6 hours
- Hospital or chest pain unit admission for suspected acute coronary syndrome
- Planned coronary CT scan
- Age ≥ 45 years old
- Normal sinus rhythm
- Patient able to give an informed consent
Exclusion Criteria:
- ST elevation MI (≥ 1mm in at least 2 contiguous leads) or unstable patients requiring urgent care
- Significant (≥ 1mm ST depression in at least 2 contiguous leads) on initial ECG
- Elevated troponin on first examination
- History of previous MI, CABG, significant Q waves on ECG or wall motion abnormality on a previous echo
- Atrial fibrillation or abundant arrhythmia
- CLBBB, Ventricular pacing
- Valvular disease of at least moderate severity
- Cardiomyopathy
- Abnormal septal motion due to right ventricular disease or lung disease
- Technically suboptimal echo study (> 2 segments of suboptimal quality from apical views)
- Pregnancy
- Inadequate strain tracing
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
---|
Chest pain
Patients who present to the emergency department with a chief complaint of chest pain and have a moderate pre-test probability for an acute coronary syndrome
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
Acute coronary syndrome
Délai: 1 week
|
1 week
|
Significant coronary artery disease.
Délai: 1 week
|
1 week
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
---|---|
Major adverse cardiac events (MACE - death, MI or revascularization)
Délai: 6 months
|
6 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Avinoam Shiran, MD, Lady Davis Carmel Medical Center, Technion, Israel Institute of Technology
Publications et liens utiles
Publications générales
- Shiran A, Blondheim DS, Shimoni S, Jabarren M, Rosenmann D, Sagie A, Leibowitz D, Leitman M, Feinberg MS, Beeri R, Adawi S, Asmer I, Ganaeem M, Friedman Z, Liel-Cohen N. Effect of image quality on accuracy of two-dimensional strain echocardiography for diagnosing ischemic chest pain: a 2DSPER multicenter trial substudy. Int J Cardiovasc Imaging. 2019 Apr;35(4):617-625. doi: 10.1007/s10554-018-1495-x. Epub 2018 Nov 14.
- Shiran A, Blondheim DS, Shimoni S, Jabarren M, Rosenmann D, Sagie A, Leibowitz D, Leitman M, Feinberg M, Beeri R, Adawi S, Shotan A, Goland S, Bloch L, Kobal SL, Liel-Cohen N. Two-dimensional strain echocardiography for diagnosing chest pain in the emergency room: a multicentre prospective study by the Israeli echo research group. Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):1016-1024. doi: 10.1093/ehjci/jew168.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Processus pathologiques
- Ischémie myocardique
- Maladies cardiaques
- Maladies cardiovasculaires
- Maladies vasculaires
- Artériosclérose
- Maladies artérielles occlusives
- La douleur
- Manifestations neurologiques
- Attributs de la maladie
- Maladie coronarienne
- Maladie de l'artère coronaire
- Urgences
- Douleur thoracique
- Syndrome coronarien aigu
Autres numéros d'identification d'étude
- 2DS-CP-ED-MSS-IERG
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .